The year in atherothrombosis.
Sanz
Javier
J
The Zena and Michael A. Wiener Cardiovascular Institute/Marie-Josee and Henry R. Kravis Center for Cardiovascular Health, Mount Sinai School of Medicine, New York, New York, USA.
Moreno
Pedro R
PR
Fuster
Valentin
V
D050197:Atherosclerosis / Q000150:complications*; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000453:epidemiology / Q000209:etiology*; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006293:Health Promotion; D006801:Humans; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D009765:Obesity / Q000150:complications; D018570:Risk Assessment; D013927:Thrombosis / Q000150:complications*
D005343:Fibrinolytic Agents; D000960:Hypolipidemic Agents